Tag: Acquisition
Regeneron Acquires 23andMe’s Biobank and Genetics Services for $256 Million to Advance Data-Driven Drug...
Highlights
Strategic Acquisition: Regeneron named successful bidder in 23andMe’s bankruptcy auction; deal valued at $256 million.
Consumer Genetics Continuity: 23andMe services to continue uninterrupted;...
Infinity BiologiX Acquires UK Based Roylance Pharma to Expand into Europe
IBX, a global leader in biobanking, bioprocessing and analytics, has acquired UK based biospecimen storage specialists Roylance Pharma.
“We are excited to welcome the Roylance...
BioIVT Acquires Tissue Solutions, a UK-based Virtual Biobank
BioIVT, a leading provider of research models and services for drug and diagnostic development, just announced the acquisition of Tissue Solutions Ltd., a virtual...
Quest Diagnostics Sells Remaining Stake in Q² Solutions to IQVIA for $760 million
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, just announced the sale of its minority share in Q2 Solutions to IQVIA (NYSE: IQV),...
Cryoport Acquires MVE Biological Solutions from Chart Industries for $320 million
Cryoport will become a leading global provider of cryogenic life sciences solutions
Acquisitions of MVE, along with CRYOPDP is expected to increase Cryoport's...
BioLife Solutions Expands The Product Line By Acquiring Custom Biogenic Systems
BioLife Solutions, Inc., a leading developer and supplier of
a portfolio of best-in-class bioproduction tools for cell and gene therapies,
today announced the acquisition of substantially...
Discovery Life Sciences™ Acquires QualTek Molecular Laboratories
Discovery Life Sciences™ (Discovery) has acquired QualTek
Molecular Laboratories (QualTek), a renowned provider of immunohistochemistry
(IHC) services with CAP/CLIA-accredited and Good Laboratory Practice-(GLP)
capable laboratories in California...
Biodesix Acquires Oncimmune’s US Based Laboratory Assets And IPN Malignancy Test
Biodesix, Inc., has completed acquisition of Oncimmune’s
laboratory and incidental pulmonary nodule (IPN) malignancy test in the United
States, further extending the company’s blood-based lung cancer...
OpGen Acquires Curetis To Advance Data-Driven Diagnostics For Infectious Disease
OpGen, Inc., and Curetis N.V., a developer of next-level
molecular diagnostic solutions, have entered into a definitive agreement to
combine the two companies’ businesses, subject to...
🔥 Popular Posts
10 Largest Biobanks in the World
Disclaimer: This article is not intended to be definitive. It was sourced from freely, openly available information on the internet. Due to the vastness...
📌 Recently Featured
Canada to Establish First National Multiple Myeloma Biobank With $6 Million Gift
Major philanthropic investment: An anonymous $6 million gift will support Canada's first national biobank dedicated exclusively to multiple myeloma research.
Research infrastructure: The...
